Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Asenapine for Acute Agitation
NCT01400113Phase 4Completed
- Sponsor
- Unity Health Toronto
- Start
- Apr 2012
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of asenapine in agitation, sponsored by Unity Health Toronto. Started Apr 2012; status: completed.
02
Drugs
asenapine
03
Conditions
agitation
Beyond the preview
Go deeper on NCT01400113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01400113.